Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia

Systemic therapies, primarily cytotoxic chemotherapies, are the mainstay treatment option for pancreatic ductal adenocarcinoma (PDAC) alongside surgery. Several guidelines exist for managing PDAC within Asia, but recommendations for systemic therapies can differ significantly. Consequently, geograph...

Full description

Saved in:
Bibliographic Details
Main Authors: D.-Y. Oh, B. Shen, S. Satoi, J. Zhou, K.-P. Kim, S.P. Choo, S.M. Woo, S.L. Chan, L. Shen, M. Ikeda
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:ESMO Gastrointestinal Oncology
Subjects:
pancreatic cancer
pancreatic ductal adenocarcinoma
systemic therapies
expert consensus
Delphi method
Asia
Online Access:http://www.sciencedirect.com/science/article/pii/S2949819825000275
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items